Resultados: 7

    WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (‎HPV)‎

    This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. This document includes guidance on an important additional option for cervical screening, the use of mRNA (messenger RNA) HPV testing. This gives countries a...

    WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions

    The objectives of these guidelines are to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and to support countries to update their national guidelines for the use of thermal ablation for cervical precancer....

    WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions

    The objectives of these guidelines are: • to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and • to support countries to update their national guidelines for the use of thermal ablation for cervical precancer. These guidelines were developed using the W...

    WHO guidelines for treatment of cervical intraepithelial neoplasia 2-3 and adenocarcinoma in situ: cryotherapy, large loop excision of the transformation zone, and cold knife conization

    Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that is diagnosed by histology as CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. There are three principal treatments for CIN available in low- and middle-income co...

    Comprehensive cervical cancer control: a guide to essential practice

    This publication, Comprehensive cervical cancer control: a guide to essential practice (C4GEP), gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and c...

    WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention

    Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. Instead of screening and diagnosis by the standard sequence of cytology, c...

    WHO guidelines Use of cryotherapy for cervical intraepithelial neoplasia

    In 2008, cervical cancer was responsible for 275 000 deaths, of which about 88% occurred in low- and middle-income countries. Cervical cancer is the third most common cancer in women worldwide and the most common cancer in many low- and middle-income countries. Because it has a typically slow progression...